Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client GD Culture Group Limited (NASDAQ: GDC)
03 nov. 2023 16h30 HE
|
Univest Securities, LLC
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York,...
Worksport Announces Pricing of Approximately $4.7 Million Registered Direct Offering & Concurrent Private Placement
31 oct. 2023 08h12 HE
|
Worksport Ltd
West Seneca, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP; WKSPW) (“Worksport” or the “Company”) is pleased to announce today that it has entered into a securities...
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
19 sept. 2023 16h05 HE
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
15 sept. 2023 09h01 HE
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 15, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Palisade Bio Announces Closing of $2 Million Registered Direct Offering Priced At Market Under Nasdaq Rules
11 sept. 2023 16h01 HE
|
Palisade Bio, Inc.
Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is...
Palisade Bio Announces $2 Million Registered Direct Offering of Common Stock Priced At Market Under Nasdaq Rules
07 sept. 2023 08h30 HE
|
Palisade Bio, Inc.
Carlsbad, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is...
ABVC BioPharma Announces Closing on $1.75 Million Registered Direct Offering
31 juil. 2023 09h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Announces Pricing of $1.75 Million Registered Direct Offering
27 juil. 2023 09h22 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, July 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
11 juil. 2023 08h30 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based...
Trust Stamp Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
01 juin 2023 08h30 HE
|
Trust Stamp
ATLANTA, June 01, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing artificial intelligence (AI)-powered trust and identity services used globally...